Listen to episode 83
Episode summary
Ryan Roghaar explores why promising medical technology can lose commercial momentum despite funding and technical strength. He examines poorly sequenced decisions, inconsistent company messaging, unsupported claims, and unclear buyers, while considering cybersecurity's place in a credible market strategy.
Key points
- Sequencing fundraising and market entry
- Matching claims with evidence
- Defining the actual buyer